Currently browsing: MYELOMA EURONET
MPE-Logo

MPE Newsletter | COVID-19 vaccination for myeloma patients

        The SARS-CoV-2 (COVID-19) pandemic has raised a lot of questions, especially around vaccination. Myeloma Patients Europe (MPE) is working to respond some of the most frequently asked questions about the current approved vaccines in Europe and how they affect myeloma and AL amyloidosis patients. MPE has developed the Q&A “SARS-CoV-2 (COVID-19) Vaccination for Myeloma Patients” to cover the...

MPE-Logo

Myeloma, AL amyloidosis and COVID-19

   Myeloma, AL amyloidosis and COVID-19   A new Myeloma Patients Europe (MPE) website section on COVID-19 (coronavirus) has been created for the compilation of documents being generated at national and global level on the management of myeloma and AL amyloidosis patients during the COVID-19 outbreak. Our main goal is to gather information and resources and make sure you have...